The world’s first gene therapy clinical trial for glygogen stoprage disease is underway at the Connecticut Children’s Medical Center and UConn Health, under the direction of pediatric endocrinologist and scientist Dr. David Weinstein. A multidisciplinary team at the Connecticut Children’s Medical Center provides comprehensive clinical care to patients, and the laboratory research is conducted at the UConn School of Medicine. more